書籍詳細

1. 神経・筋の基礎

P.12 掲載の参考文献

• 1) Huxley, H. E.: In The Structure and Function of Muscle (Bourne, G. H., Ed.), Vol. 1, Academic Press, New York and London, P. 302, 1972.

• 2) Ebashi, S. and Nonomura, Y.: In The Structure and Function of Muscle (Bourne, G. H., Ed.), Vol. 3, Academic Press, New York and London, P. 286, 1973.

• 3) Gordon, A. M., Huxley, A. F. and Julian, F. L.: J. Physiol., 184, 170, 1966.

• 4) Mair, W. G. P. and Tome, F. M. S.: Atlas of the Ultrastructure of Diseased Human Muscle, Churchill Livingstone, Edinburgh and London, 1972.

• 5) Ishikawa, H., Fukuda, Y. and Yamada, E.: J. Electron Micr., 24, 97, 1975.

• 6) Ellisman, M. H., Rash, J. E., Staehelin, LA. and Porter, K. R.: J. Cell Biol, 68: 752, 1976.
  pubmed

• 7) Huxley, H. E.: Nature, 202: 197, 1964.

• 8) Peachey, L. D.: J. Cell Biol., 25: 209., 1965.

• 9) Ishikawa, H. and Tsukita, S.: J. Electron Micr., 26: Suppl., 359, 1977.

• 10) Oguchi, K. and Tsukagoshi,: H.: J. Neurol. Sci., 41: 161, 1980.

• 11) Ishikawa, H.: J. Cell Biol., 38: 51, 1968.
  pubmed

• 12) Schotland, D. L.: J. Neuropath. Exp. Neurol., 27: 109, 1968.
  pubmed

• 13) Porter, K. R. and Palade, GE.: J. Biophys. Biochem. Cytol., 3: 269, 1957.
  pubmed

• 14) Bailey, C. H. and Peachey, L. D.: 33rd Ann. Proc. Electron Microscopy Soc. Amer., Las Vegas, Nevada, 552, 1975.

• 15) Peachey, L.D. and Huxley, A. F.: J. Cell Biol. 13: 177, 1962.
  pubmed

• 16) Kelly, DE.: J. Ultrastruct. Res., 29: 37, 1969.
  pubmed

• 17) Franzini-Armstrong, C.: J. Cell Biol., 47: 488, 1970.
  pubmed

• 18) Pellegrino, C. and Franzini, C.: J. Cell Biol., 17: 327, 1963.
  pubmed

• 19) Peachey, L.D.: Ann. N. Y. Acad. Sci., 137: 1025, 1966.
  pubmed

• 20) Dubowitz, V. and Pearse, A. G. E.: Nature, 185: 701, 1960.

• 21) Gauthier, G. T.: Z. Zellforsch., 95: 462, 1969.

• 22) Eisenberg, B. R. and Kuda, A. M.: J. Ultrastruct. Res. 54: 76, 1976.
  pubmed

• 23) Peter, J., Barnard, R., Edgerton, V., Gillespie, C, and Stempel, K.: Biochemistry, 11: 2627, 1972.

• 24) Buller, AJ., Eccles, J. C. and Eccles, R. M.: J. Physiol., 150: 417, 1960.
  pubmed

• 25) Close, R.: Nature, 206: 831, 1965.
  pubmed

• 26) Dubowitz, V.: J. Physiol., 193: 481, 1967.
  pubmed

• 27) Carlson, B. M.: Amer. J. Anat., 137: 119, 1973.
  pubmed

• 28) Mauro, A.: J. Biophys. Biochem. Cytol, 9: 493, 1961.

• 29) Schmalbruch, H. and Hellhammer, U.: Anat. Rec., 189: 169, 1977.
  pubmed

• 30) Ichikawa, A. and Ichikawa, M.: In Recent Progress in Electron Microscopy (Yamada, E., Mizuhira, V., Kurozumi, K. and Nagano, T., Eds.), Igaku-shoin, Tokyo, P. 49, 1976.

P.22 掲載の参考文献

• 1) 筋肉のなぞ, 丸山工作, 岩波新書, 1980.

• 2) 筋収縮の制御, 丸山工作, 岩波書店, 1976.

• 3) 筋運動の進化, 杉晴夫, 東大出版会, 1977.

• 4) Cross-bridge mechanism in muscle contraction: Ed. by H. Sugi & G. H. Pollack, Univ. of Tokyo, Press. 1978.

• 5) Muscle contraction: Ed. by S. Ebashi, K. Maruyama, M. Endo., Japan Scientific Societies Press, Tokyo, 1980.

• 6) 筋収縮の制御-トロポニンの役割をめぐって-, 丸山工作, 江橋節郎. 蛋白質. 核酸, 酵素, 20: 426-440, 1975.

• 7) 筋肉・神経の機能とカルシウムイオン, 若林健之, 代謝, 6: 865-873, 1969.

• 8) 筋収縮のしくみ. 真崎知生, 江橋節郎, 化学と生物, 4: 338-344, 1966.

• 9) 筋収縮とCa, 大槻磐男, 日本臨床, 30: 722-728, 1972.
  Medical*Online

P.34 掲載の参考文献

• 1) Slater, E. C.: Biochemistry of sarcomeres, In "The structure and Function of Muscle" (Ed, Bourne, G. H.) Vol II, Academic Press, New York. P. 105, 1960,

• 2) Dubowitz, V. and Pearse, A. G.E.: Reciprocal relationship of phosphorylase and oxidative enzymes in skeletal muscle. Nature (Lond), 185: 701, 1960.

• 3) Walton, J. N.: Disorders of voluntary Muscle. Churchill Livingstone, London, 3rd ed. 1974.

• 4) 庄司進一, 杉田秀夫: クレアチンフォスフォキナーゼ (CPK) とそのアイソエンザイム, 日本臨牀, 34: 2501, 1976.
  Medical*Online

• 5) Eppenberger, H. M., Eppenberger, M., Richterich, R.: The ontogeny of creatine kinase isozymes. Develop. Biol. 10: 1, 1964.
  pubmed

• 6) 植田啓嗣, 中田俊士, 大原俊樹, 畑中良夫, 浜口知昭, 城山美穂子: アルドラーゼ-その数値をどう読むか-, 日本臨床, 34: 2513, 1976.
  Medical*Online

• 7) 植田啓嗣: 可溶性酵素, 筋の構造と機能 (酒井敏夫, 遠藤実, 杉田秀夫編) 医学書院, p. 557, 1977.

• 8) 小沢えい二郎: 筋収縮時における解糖の制御, 筋の構造と機能 (酒井敏夫, 遠藤実, 杉田秀夫編) 医学書院, p. 374, 1977.

• 9) McArdle, B.: Myopathy due to a defect in muscle glycogen break-down. Clin. Sci. 10: 13, 1951.

• 10) Tarui, S., Okuno, G., Okura, Y., Tanaka, T., Suda, M. and Nishikawa, M.: Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis. Biochem. biophys. Res. Commun., 19: 517, 1965.

• 11) Heyck, H. and Laudahn, G.: Die progressive-dystrophischen Myopathien. Springer-Verlag, Berlin, Heidelberg, New York, P. 179, 1969.

• 12) Vignos, P.J., Lefkowitz, M.: A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy. J. Clin. Invest. 38: 873, 1959.

• 13) Sibley, J. A. and Lehninger, A. L.: Aldolase in the serum and tissues of tumor bearing animals, J. Natl. Cancer Inst. 9: 303, 1949.
  pubmed

• 14) Pearson, C. M.: Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases, I. Serum glutamic oxal oacetic transaminase, New Eng. J. Med. 256: 1069, 1957.

• 15) Dreyfus, J. C., Schapia, G. and Schapia, F.: Serum enzymes in the physiopathology of muscle, Ann. N. Y. Acad. Sci. 75: 235, 1958.

• 16) Ebashi, S., Toyokura, Y., Momoi, H. and Sugita, H.: High creatine phosphokinase activity of sera with progressive muscular dystrophy, J. Biochem. 46: 103, 1959.

• 17) 杉田秀夫, 古川哲雄, 千葉恵子: クレアチンフォスフォキナーゼ (CPK) -その数値をどう読むか-, 日本臨牀, 27: 1072, 1967.

• 18) Roses, A.D., Roses, M.J., Nicholson, G. A. and Roe, C. R.: Lactate dehydrogenase isoenzyme 5 in detecting carriers of Duchenne muscular dystrophy. Neurol. 27: 414, 1977.

• 19) Engel, W. K.: The essentiality of histo-and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease. Neurol. 12: 778, 1962.

• 20) Brooke, M.H.& Kaiser, K. K.: Muscle fiber types;How many and what kind? Arch. Neurol. 23: 369, 1970.
  pubmed

• 21) Dubowitz, V.& Brooke, MH.: Muscle Biopsy;A Modern Approach. Saunders, London, Philadelphia. Toronto. P. 51, 66, 1973.

• 22) McComas, A.J.: Neuromuscular function and disorders, Butterworths, London-Boston, p. 62, 1977.

• 23) Peter, J.B., Barnard, RJ., Edgerton, V. R., Gillespie, C. A. and Stempel, K. E: Metabolic profiles of three fiber types of skeletal muscle in guinea pigs and rabbits. Biochemistry. 11: 2627, 1972.
  pubmed

P.46 掲載の参考文献

• 1) Potter, L. T.: Synthesis, storage, and release of 14C acetylcholine in isolated rat diaphragm. J. Physiol. Lond., 206: 145-166, 1970.
  pubmed

• 2) Hubbard, J. I.: Microphysiology of vertebrate neuromuscular transmission. Physiol. Rev., 53: 674-733, 1973.
  pubmed

• 3) Edward, D. A.: Modulation of postjunctional cholinergic sensitivity of rat diaphragm muscle by cyclic adenosine monophosphate. J. Membrane Biol., 29: 67-79, 1976.

• 4) Drachman, D. B. [Editor]: Trophic functions of the neuron. Ann. N. Y. Acad. Sci., 288: 1-423, 1971.

• 5) Elmqvist, D. and Quastel, D. M. J.: A quantitative study of end-plate potentials in isolated human muscle. J. Physiol. Lond., 178: 505-529, 1965.

• 6) Katz, B. and Miledi, R.: The binding of acetylcholine to receptors and its removal from the synaptic cleft. J. Physiol. Lond., 231: 549-574, 1973.
  pubmed

• 7) Raftery, M. A, Hunkapiller, M. W., Strader, C. D. and Hood, L. E.: Acetylcholine receptor: Complex of homologous subunits. Science, 208: 1454-1457, 1980.
  pubmed

• 8) Lindstrom, J., Einarson, B. and Merlie, J.: Immunization of rats with polypeptide chain from torpedo receptor causes an autoimmune response to receptors in rat muscle. Proc. Nat. Acad. Sci. USA, 75: 769-773, 1978.
  pubmed

• 10) Israel, M., Lesbats, B., Manarashe, R., Marsal, J., Mastour-Frachon, P. and Meunier, F. M.: Related changes in amounts of ACh and ATP in resting and active Torpedo nerve electroplaque synapses. J. Neurochem., 28: 1259-1267, 1977.

• 11) Michaelson, D. M., Avissar, S., Kloog, Y. and Soholovsky, M.: Mechanism of acetylcholine release: Possible involvement of presynaptic muscarinic receptors in regulation of acetylcholine release and protein phosphorylation. Proc. Nat. Acad. Sci. USA, 76: 6336-6340, 1979.

• 12) Chang, H. W. and Neumann, E.: Dynamic properties of isolated acetylcholine receptor protein: Release of calcium ions caused by acetyl. choline binding. Proc. Nat. Acad. Sci. USA, 73: 3364-3368, 1976.

• 13) Bender, A. N, Ringel, S. P. and Engel, W. K.: The acetylcholine receptor in normal and pathologic states. Neurology Minneap., 26: 477-483, 1976.

• 14) Weinberg, C. B. and Hall, Z. W.: Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors. Proc. Nat. Acad. Sci. U. S. A., 76: 504-508, 1979.
  pubmed

• 15) 高守正治: 神経筋疾患とTrophic Factors. 神経研究の進歩, 20: 594-604, 1976

• 16) Albuquerque, E. X., Barnard, E. A., Chiu, T. H., Lapa, A. J., Dolly, J. O., Jansson, S. E., Daly, J. and Witkop, B.: Acetylcholine receptor and ion conductance modulator sites at the murine neuromuscular junction: Evidence from specific toxin reactions. Proc. Nat. Acad. Sci. USA, 70: 949-953, 1973.
  pubmed

• 17) Elliott, J., Dunn, SJ., Blanchard, S. G. and Raftery, M. A.: Specific binding of perhyrohistrionicotoxin to Torpedo acetylcholine receptor. Proc. Nat. Acad. Sci. USA, 76: 2576-2579, 1979.

• 18) Saitoh, T., Oswald, R., Wennogle, L.P. and Changeux, J P.: Conditions for the relative labelling of the 66, O00 dalton chain of the acetylcho line erceptor by covalent non-competitive blocker 5-azido-[3H]tri-methisoquin. FEBS Lett., 116: 30-36, 1980.

• 19) Takamori, M., Ide, Y. and Kasai, M.: Neuromuscular defect after suppression of ion conductance. Neurology Minneap., 29: 772-779, 1979.

• 20) Eldefrawi, A. T., Eldefrawi, ME., Albuquerque, E. X., Oliveria, A. C., Mansour, N., Adler, M., Daly, J. W., Brown, G. B., Burgermeister, W. and Witkop, B.: Perhydrohistrionicotoxin: A potential ligand for the ion conductance modulator of the acetylcholine receptor. Proc. Nat. Acad. Sci. USA, 74: 2172-2176, 1977.

• 21) Burgermeister, W., Catterall, W. A. and Witkop, B.: Histrionicotoxin enhances agonist-induced desensitization of acetylcholine receptor. Proc. Nat. Acad. Sci. USA, 74: 5754-5758, 1977.
  pubmed

• 22) Katz, B. and Miledi, R.: The statistical nature of the acetylcholine potential and its molecular components. J. Physiol. Lond., 224: 665-699, 1972.
  pubmed

• 23) Magleby, K. L. and Stevens, C. F. . A quantitative description of end-plate currents. J. Physiol. Lond., 223: 173-197, 1972.
  pubmed

• 24) 高守正治, 辻畑光宏, 井手芳彦, 峰 雅宣, 江口勝美: M.G.の病因・病態-神経筋接合部の電気生理, 超微形態, 免疫学的側面. 脳と神経, 32: 891-908, 1980.

• 25) Takamori, M., Mori, M. and Kasai, M.: Experimental autoimmune myasthenia gravis and cholinergic ionophore: An electrophysiologic study. Neurology. Minneap., 29: 945-950, 1979.

• 26) Takamori, M., Mori, M., Ide, Y. and Kasai, M.: Effects of epinephrine, ouabain, and insulin in experimental autoimmune myasthenia gravis. Neurology. Minneap., 30: 167-171, 1980.

• 27) Takamori, M., Ishii, N. and Mori, M.: The role of cyclic 3', 5'-adenosine monophosphate in neuromuscular transmission. Arch. Neurol. Chicago, 29: 420-423, 1973.
  pubmed

• 28) Takamori, M.: Nerve, muscle, and serotonin. J. Neurol. Neurosurg. Psychiatry, 40: 89-96, 1977.
  pubmed

• 29) Takamori, M.: Caffeine, calcium, and Eaton-Lambert syndrome. Arch. Neurol. Chicago, 27: 285-291, 1972.
  pubmed

• 30) Lentz, T. L.: Neurotrophic regulation at the neuromuscular junction. Ann. N. Y. Acad. Sci., 228: 323-337, 1974.
  pubmed

• 31) 高守正治: 新小児医学大系第15巻, 小児運動器病学, 中山書店, 1981, (印刷中)

• 32) Lennon, V. A., and Lambert, E. H.: Monoclonal autoantibodies to acwtylcholine receptors: Evidence for a dominant idiotype and requirement of complement for pathogenisity. Ann. N. Y. Acad. Sci. 377: 77-96, 1981.

• 33) Tzartos, S. J., Seybold, M. E., and Lindstrom, J. M.: Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Prc. Natl. Acad. Sci. USA 79: 188-192, 1982.

• 34) Berrih, S., Gaud, C., Bach, M-A., Le Brigand, H., Binet, J. P., and Bach, J. F.: Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. Clin. exp. Immunol. 45: 1-8, 1981.
  pubmed

• g) Barnard, E. A., Dolly, J. O., Porter, C. W. and Albuquerque, E. X.: The acetylcholine receptor and the ionic conductance modulator system of skeletal muscle. Exp. Neurol., 48: 1-28, 1975.

P.58 掲載の参考文献

• 1) Robertson, J. D.: New observations of the ultrastructure of membrane of frog peripheral nerve fibers. J. Biophys. Biochem. Cytol., 3: 1043, 1957.
  pubmed

• 2) Burton, P. R.: Optical diffraction and translational microtubules having a prominant helical wall structre J. Cell. Biol., 44: 693, 1970.

• 3) Kirkpatrik, J. B., Hyams, L, Thomas, U. L. and Howley, P. M.: Purification of intakt microtubules from brain. J. Cell. Biol, 47: 384, 1970.

• 4) Wuerker, R. B. and Kirkpatrick, J. B.: Neuronal microtubules, neurofilaments and microfilaments. Int. Rev. Cytol., 33: 45, 1972.
  pubmed

• 5) Wuerkre, RB.: Neurofilaments and glia filaments. Tissue and Cell, 2: 1, 1970.

• 6) Schmidt, H. D.: On the construction of the dark or double bordered nerve fiber. Mono. Micros. J., London., 11: 200, 1874.

• 7) Lanterman, AJ.: Uber den feineren Bau der mark haltigen neven fasern. Arch. Microsk. Anat. Endtwicklungswech., 13: 1, 1877.

• 8) Ranvier, L.: Recherches sur I'histologie et la phisiologie des nerfs. Arch. Physiol., I. Ser., 4: 129, 1971.

• 9) Dentler, W. L., Granett, S., Witman, G. B. & Rosenbaum, J. L.: Directionality of brain microtubule assembly in vitro. Proc. Nat. Acad. Sci. USA, 71: 1710, 1974.
  pubmed

• 10) Krygier-Brevart, V., Weiss, D. G., Mehl, E., Schubert, P. & Kreutzberg, G. W.: Maitenance of synaptic membranes by the fast axonal flow Brain Res., 77: 97, 1974.

• 11) 黒川正則: 軸索内輸送の諸問題, 特定研究「神経科学」研究報告書, 2: 183, 1976.

• 12) Ranson, S. W., Droegemueller, W. H., Davenport, K. And Fisher, C.: Number, size and myelination of the sensory fibers in the cerebrospinal nerves. Proc. Ass. Res. Nerv. Ment. Dis., 15: 3, 1934.

• 13) O: Sullivan, D. J. and Swallow, M.: The fiber size and content of the radial and sural nerves. J. Neurosurg. Psychiatry, 31: 464, 1968.

• 14) Erlanger, & Gasser, H. S.: Electrical signs of nervous activity, Johnson Foundation Lectures, University of Pensylvania Press, Philadelphia. 1937.

• 15) Lloide, D. P. C. & Chang, H. T.: Afferent fibers in nerves. J. Neurophysiol. 11: 199, 1948.

2. 診断

P.83 掲載の参考文献

• 1) Classification of the Neuromuscular Disorders, Minutes of the Meeting of the Research Group on Neuromuscular Diseases. J. Neurol. Sci. 6: 165-177, 1968.

• 2) 祖父江逸郎: 末梢性ニューロパチー (概説), 末梢神経障害のすべて, 内科シリーズ No.26, 南江堂, 東京, p.7-8, 1977.

• 3) 祖父江逸郎: 感染症に伴うニューロパチー, 祖父江逸郎, 椿忠雄, 里吉営二郎編. 神経病学, 金原出版, 東京, p.557-558, 1979.

• 4) 祖父江逸郎: 中毒性ニューロパチー, 祖父江逸郎, 椿忠雄, 里吉営二郎編. 神経病学, 金原出版, 東京, p.589-594, 1979.

• 5) Rowlandによるミオパチーの分類 1964, 荒木淑郎: 日本におけるミオパチーの実態, 第17回日本医学会総会学術講演集IV, 日本医書出版協会, 1967, より引用.

• 6) 加瀬正夫, 伊藤清: 神経・筋疾患診断のすすめ方, 日本臨牀, 27: 2-12, 1969.

• 7) 里吉営二郎: ミオパチーの分類とベッドサイドにおける診断の進め方, 臨床科学, 14: 811-816, 1978.

P.103 掲載の参考文献

• 1) 藤原哲司: 神経伝導速速度測定と臨床応用, 内科セミナー PN2. 脳波・筋電図. 祖父江逸郎 他編256頁 永井書店, 大阪1981.

• 2) 森宗 勧, 西谷 裕: Harvey-Masland Test. 日本臨牀, 31: 70, 1973.

• 3) 西谷 裕, 小西哲郎: Single fiber EMG-各パラメーターとその意義- 臨床脳波 22: 790, 1980.

• 4) Dubowitz, V. and Brooke, M. H.: Muscle biopsy: a modern approach. P. 51. Saunders Co. Ltd. London, 1973.

• 5) 宇尾野公義, 木下真男: 筋病理アトラス. 23頁, 医学書院, 東京, 1972.

• 6) Saida, K., Mendell, J. R. and Weiss, H. S.: Peripheral nerve changes induced by methyl n-butyl ketone and potentiation by methyl ethyl ketone. J. Neuropath. exp. Neurol 35: 207, 1976.

• 7) Bradley, W. G.: Disorders of peripheral nerves. Blackwell. Sci. Publ. P. 129, London, 1974.

• 8) Ebashi, S., Toyokura, Y., Momoi, H. & Sugita, H.: High creatine phosphokinase activity of sera of progressive muscular dystrophy patients. J. Biochem. (Tokyo), 46: 103, 1959.

3. 神経・筋疾患の病態と原因

P.114 掲載の参考文献

• 1) Albers, R. W. et al.: Basic Nourochemistry. Little, Brown and Comp., Boston, 1972.

• 2) Mukoyama, M. & Matsuoka, Y.: Correlation between pathological alterations and functional disorders in the peripheral neuropathies. Jap. J. Med., 12: 105, 1973.

• 3) 向山昌邦, 他: 糖尿病における末梢神経, 筋障害の病理学的研究. 臨床神経, 12: 649, 1972 (会)

• 4) Danta, G.: Hypoglycemic peripheral neuropathy. Arch. Neurol, 21: 121, 1969.
  pubmed

• 5) Dayan, A. D.: Peripheral neuropathy of metachromatic leucodystrophy: observations on segmental demyelination and remyelination and the intracellular distribution of sulphatide. J. Neurol. Neurosurg. Psychiat., 30: 311, 1967.
  pubmed

• 6) Ohnishi, A. & Dyck, PJ.: Loss of small peripheral sensory neurons in Fabry's disease. Arch. Neurol, 31: 120, 1974.

• 7) Refsum, S.: Heredopathia atactica polyneuritiformis: Familial syndrome not hitherto described: Contribution to clinical study of hereditary disease of nervous system. Acta Psychiat. Neurol. Suppl., 38: 303, 1946.

• 8) Fardeau, M. & Engel, W. K.: Ultrastructural study of a peripheral nerve biopsy in Refsum's disease. J Neuropathol. Exp. Neurol., 28: 278, 1969.
  pubmed

• 9) Kocen, R. S. et al: Nerve biopsy findings in two cases of Tangier disease. Acta neuropathol., 26: 317, 1973.
  pubmed

• 10) Karpati, G. et al.: The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical and pathologic features. Neurology, 25: 16, 1975.

• 11) 金久禎秀, 他: 夏期に発生した下肢浮腫を伴う若年性多発性神経炎. 5症例の報告. 臨床神経, 16: 244, 1976.

• 12) Gammon, P. D. et al.: Neural toxicity in tuberculous patients treated with isoniazid (isonicotinic acid hydrazid) . Arch. Neurol. Psychiat., 70: 64, 1953.

• 13) 柴崎 浩, 村井由之: Pellagrous neuropathyの1例. 臨床神経, 7: 9, 1967.

• 14) Mayer, R. F.: Peripheral nerve function in vitamin B12 deficiency. Arch. Neurol., 13: 355, 1965.
  pubmed

• 15) Vicale, C. T.: The diagnostic features of a muscular syndrome resulting from hyperparathyroidism, osteomalacia owing to renal tubular acidosis, and perhaps to related disorders of calcium metabolism. Trans. Am. Neurol. Assoc., 74: 143, 1949.

• 16) 里吉営二郎, 他: 周期性四肢麻痺発現の機序に関する新しい見解. 臨内小, 16: 1179, 1961.

• 17) 向山昌邦, 斉藤勝 : 周期性四肢麻痺. 臨床成人病, 8. 788, 1978.

• 18) 斉藤勝, 向山昌邦, 他: 著明な壊死性変化がみられたhypokalemic myopathy症例. 神経内科, 1: 341, 1974.

• 19) 榊原敏正, 向山昌邦, 他: 周期性四肢麻痺とhypokalemic myopathyの関連. 臨床神経, 19: 77, 1979.

• 20) 大西晃生, 他: アルコール性多発神経炎における腓腹神経病変の微細構造について. 臨床神経, 12: 64, 1972.

• 21) Dinn, JJ. & Crane, D. L.: Schwann cell dysfunction in uraemia. J. Neurol. Neurosurg. Psychiat., 33: 605, 1970.
  pubmed

• 22) Dayan, A. D. & Williams, R.: Demyelinating Peripheral neuropathy and liver disease. Lancet, 2: 133, 1967.
  pubmed

• 23) 寺本純, 向山昌邦, 他: 肝硬変症に合併した再発性多発性神経炎の1例. 神経内科, 6: 527, 1977.

• 24) DiFiore, CJ. A.: Acute muscular atophy with porphyria. Med. Clin. North Am., 30: 397, 1946.

• 25) Cavanagh, J. B. & Ridley, A. R.: The nature of the neuropathy complicating acute intermittent porphyria. Lancet, 2: 1023, 1967.
  pubmed

• 26) Munsat, T. L. & Poussaint, A. F.: Clinical manifestations and diagnosis of amyloid polyneuropathy. Report of 3 cases. Neurology, 12: 413, 1962.

• 27) 調輝男, 他: 末梢神経および自律神経障害を主徴とした家族性原発性amyloid沈着症の病理学的研究. 神経進歩, 13: 206, 1969.

• 28) Logothetis, J. et al.: Cryoglobulinemic neuropathy: incidence and clinical characteristics. Arch. Neurol., 19: 389, 1968.

• 29) Iwashita, H. et al.: Polyneuropathy in Waldenstrom: s macroglobulinemia. J. Neurol. Sci., 21: 341, 1974.
  pubmed

• 30) 寺本純, 向山昌邦, 他: 免疫グロブリン異常, 肝脾腫, 腹水, 皮膚色素沈着, 唾液腺腫大などを伴う多発性神経炎の1例, 神経内科, 7: 500, 1977.

• 31) 平山幹生, 向山昌邦, 他: 特異な症候を伴う慢性多発性神経炎の2例. 神経内科, 7: 494, 1977.

P.122 掲載の参考文献

• 1) Ord, W. M.: On some disorders of nutrition related with affections of the nervous system. Brit. Med. J. 2: 205, 1884.

• 2) Nickel, S. N. and Frame, B.: Neurologic manifestations of myxedema. Neurology, 8: 511, 1958.
  pubmed

• 3) Wilkinson, JH. and Robinson, J. M.: Effect of ATP on release of intracellular enzymes from damaged cells. Nature, 249: 662, 1974.
  pubmed

• 4) Buchthal, F.: Electrophysiological abnormalities in metabolic myopathies and neuropathies. Acta neurol. Scand. 46 Suppl: 129, 1970.

• 5) Ramsay, I. D.: Muscle dysfunction in hyperthyroidism. Lancet. 2: 931, 1966.
  pubmed

• 6) Okinaka, S., Shizume, K., Iino, S., Watanabe, A., Irie, M., Noguchi, A., Kuma, S., Kuma, K. and Ito, T.: The association of periodic paralysis and hyperthyroidism in Japan. J. Clin. Endocr. 17: 1454, 1957.

• 7) Norris, F. H., Panner, BJ. and Stormont, B. M.: Thyrotoxic periodic paralysis. Metabolic and ultrastructural studies. Arch. Neurol. 19: 88, 1968.

• 8) Norris, F. H.: Status of the segmental innervation in thyrotoxic periodic paralysis. E lectroenceph. Clin. Neurophysiol. 21: 67, 1966.

• 9) Millikan, C. H. and Haines, S. F.: The thyroid gland in relation to neuromuscular disease. Arch. intern. Med. 92: 5, 1953.
  pubmed

• 10) Engel, A. G.: Thyroid function and myasthenic gravis. Arch. Neurol. 4: 663, 1961.

• 11) Drachman, D. B.: Myasthenia gravis and the thyroid gland. New Engl. J. Med. 266: 330, 1962.

• 12) Karpati, G. and Frame, B.: Neuropsychiatric disorders in Primary hyperparathyroidism. Clinical analysis with review of the literature. Arch. Neurol. 10: 387, 1964.
  pubmed

• 13) Smith, R. and Stern, G: Muscular weakness in osteomalacia and hyperparathyroidism. J. neurol. Sci. 8: 511, 1969.
  pubmed

• 14) Bischoff, A and Esslen, E.: Myopathy with primary hyperparathyro. idism. Neurology. 15: 64, 1965.
  pubmed

• 15) Mastaglia, F. L., Barwick, D. D. and Hall, R.: Myopathy in acromegaly. Lancet. 2: 907, 1970.

• 16) Picket, JB., Layzer, R. B., Levin, S. R., Schneider, V., Campbell, M. J. and Sumner, A. J.: Neuromuscular complications of acromegaly. Neurology. 25: 638, 1975.

• 17) Schiller, F. and Kolb, F. O.: Carpal tunnel syndrome in acromegaly. Neurology. 4: 271, 1954.
  pubmed

• 18) Byers, R. K, Bergman, A. B. and Joseph, M. C.: Steroid myopathy. Report of five cases occurring during treatment of rheumatic fever. Pediatrics. 29: 26, 1962.

• 19) Bull, G. M., Carter, A. B. and Lowe, K. G.: Hyperpotassaemic paralysis. Lancet, 2: 60, 1953.

• 20) Marks, L. J. and Feit, E.: Flaccid quadriplegia, hyperkalemia, and Addison: s disease. Arch. intern. Med. 91: 56, 1953.
  pubmed

• 21) Pollen, R. H. and Williams, R. H. W.: Hyperkalemic neuromyopathy in Addison: s disease. New Engl. J. Med. 263: 273, 1960.

• 22) Faw, M.L. and Ewer, R. W.: Intermittent paralysis and chronic adrenal insufficiency. Ann. intern. Med. 57: 461, 1962.
  pubmed

• 23) Van Dellen, R. G. and Purnell, D. C.: Hyperkalemic paralysis in Addison: s disease. Proc. Mayo. Clin. 44: 904, 1969.
  pubmed

• 24) Conn, J. W., Knopt, R. F. and Nesbit, R. M.: Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Amer. J. Surg. 107: 159, 1964.

• 25) Foye, L.V. and Feichtmeir, T. V.: Adrenal cortical carcinoma producing solely mineralocorticoid effect. Amer. J. Med. 19: 966, 1955.

• 26) Sambrook, MA, Heron, J. R and Aber, G. M.: Myopathy in association with primary hyperaldsteronism. J. Neurosurg. Psychiat. 35: 202, 1972.

• 27) 安徳恭演, 岩下宏, 後藤幾生, 黒岩義五郎, 小林卓郎, 大西晃生: 糖尿病に伴う混合型肥厚性ポリニューロパチーについての検討. 神経内科, 10: 65, 1979.

• 28) 小串俊雄, 早川享, 楠亮二, 後藤幾生: 糖尿病患者にみられたRecurrent cranial neuropathyの1例. 日本臨床, 33: 2401, 1975.

• 29) Wolman, H. W. and Wilder, R. M.: Diabetes mellitus: Pathological changes in the spinal cord and peripheral nerves. Arch. Intern. Med. 44: 5760-1929.

P.135 掲載の参考文献

• 1) 中江公裕, 井形昭弘: SMON発症とキノホルム投与状況との関連についての理論的考察, 医学のあゆみ, 76: 667, 1971.

• 2) 塚越 広ほか: SMONにおける末梢神経障害. I. 腓腹神経生検による病理組織学的検討. 臨床神経, 11: 392, 1971.

• 3) Lovelace, R. E., Horwitz, SJ.: Peripheral neuropathy in long-term diphenylhydantoin therapy. Arch. Neurol 18: 69, 1968.
  pubmed

• 4) 祖父江逸郎ほか: 抗結核剤ニューロパチーとくにエタンブトールニューロパチーとスモンの比較. 神経進歩, 17: 106, 1973.

• 5) 浜田陸三: 慢性有機水銀中毒症に関する臨床的研究. 鹿大医誌, 32: 197, 1980.

• 6) Hunter, D. et al.: Poisoning by methyl mercury compounds. Ouart. J. Med. 9: 193, 1940.

• 7) Igisu, H. et al.: Acrylamide encephaloneuropathy due to well water pollution. J. Neurol Neurosurg. Psychiat. 38: 581, 1975.
  pubmed

• 8) Aring, C. D.: The systemic nervous affinity of trioithocresylphosphate (Jamaican ginger palsy) . Brain. 65: 34, 1942.

• 9) Hed, R. et al.: Acute myoglobulinuria. Report of a case with a fatal outcome. Acta Med. Scand. 152: 459, 1955.

• 10) Lane, R. J. M. et al.: Epsilon aminocaproic acid (EACA) myopathy. Postgrad. Med. J. 55: 282, 1979.

• 11) Macdonald, R. D. and Engel, A. G.: Experimental chloroquine myopathy. J. Neuropatho l. Exp. Neurol. 29: 479, 1970.

4. 神経・筋疾患の臨床

P.156 掲載の参考文献

• 1) Becker, P. E. and Kiener, F.: Eine neue X-chromosomale Muskeldystrophie. Arch. Psychiat. Z. Neurol, 193: 427-448, 1955.

• 2) Duchenne, G. B. A.: Recherches sur Ia paralyse musculaire pseudohy-pertrophique ou paralysie myosclerosique. Arch. Gen. Med., 11: 5, 179, 209, 305, 421, 552, 1868.

• 3) Ebashi, S., Toyokura, Y., Momoi, H. and Sugita, H.: High creatine phosphokinase activity of sera of progressive muscular dystrophy. J. Biochem., 46: 103-104, 1959.

• 4) Erb, W. H.: Ueber die"Juvenile Form"der progressiven Muskelatrophie und ihre Beziehungen zur sogenanten Pseudohypertrophie der Muskeln. Dtsch. Arch. Klin. Med., 34: 467-519, 1884.

• 5) Fitch, C. D., Lucy, D. D., Bornhofen, J. H. and Dalrymple, G. V.: Creatine metabolism in skeletal muscle. II Creatine kinetics in man. Neurology, 18: 32-42, 1968.
  pubmed

• 6) Fukuyama, Y., Kawazura, M. and Haruna, H.: Apeculiar form of congenital progressive muscular dystrophy. Pediat. Univ. Tokyo, 4: 5-7, 1960.

• 7) 福山幸夫: 進行性筋ジストロフィー症-筋緊張症候群をふくむ-, 筋肉病学 (里吉営二郎, 豊倉康夫編), 南江堂, 東京, p. 387-440, 1973.

• 8) Kuroiwa, Y. and Miyazaki, T.: Epidemiological study of myopathy in Japan. Exploratory concepts in muscular dystrophy and related disorders (Milhorat, A., editor), Excerpta Medica, Amsterdam, 98-102, 1967.

• 9) 三好和夫, 多田嘉明, 川井尚臣ら: 進行性筋ジストロフィー症の悪性肢帯型 malignant limb-girdle type. この型の存在と本症分類上における意義. 厚生省進行性筋ジストロフィー症研究班業績集, 2: 39-49, 1974.

• 10) 三好和夫, 多田嘉明, 川井尚臣ら: 筋ジストロフィー症の遺伝. 神経内科, 3: 113-122, 1975.

• 11) 三好和夫: 内科学の展望 (第4回), 筋疾患を中心として, (5) 筋ジストロフィー症の遺伝・臨床型. 日内会誌, 66: 769-775, 1977.

• 12) 三好和夫, 岩朝勝, 川井尚臣ら, : 常染色体劣性末梢型筋ジストロフィー症 Autosomal recessive distal muscular dystrophy-わが国にとくにみられる新しい末梢型筋ジストロフィー症-. 日本臨牀, 35: 3922-3928, 1977.
  Medical*Online

• 13) 三好和夫, 川井尚臣, 佐々木尚子ら: 進行性筋ジストロフィー症の遺伝・臨床型と生化学的指標としてのクレアチン・キナーゼとミオグロビン. 日本臨牀, 35: 3891-3896, 1977.
  Medical*Online

• 14) Miyoshi, K., Saito, S., Kawai, H., Kondo, A., Iwasa, M., Hayashi, T and Yagita, M.: Radioimmunoassay for human myoglobin: methods and results in patients with skeletal muscle or myocardial disorders. J. Lab. Clin. Med., 92: 341-352, 1978.
  pubmed

• 15) 三好和夫, 佐々木尚子, 川井尚臣ら: 日本における筋ジストロフィー症の prevalence rate および mutation rate. 四国医誌, 36: 457-461, 1980.

• 16) 三好和夫: 筋ジストロフィー症における代謝異常. 難病の発症機構. 文部省特定研究「難病」班(豊倉康夫代表) 東京大学出版会, 東京 P 213-232, 1981.

• 17) Morton, N. E, Chung, C. S. and Peters, H. A.: Genetics of muscular dystrophy. In"Muscular dystrophy in man and animals" (ed. by Bourne, G. H. and Golarz, Ma. N.), S Karger, Basel, P. 324-365, 1963.

• 18) 冲中重雄, 三好和夫, 木村栄一 : 一卵性双生児にみられた筋ジストロフィー症. 脳と神経, 2: 193-196, 1950.

• 19) Rowland, L.P.: Pathogenesis of human muscular dystrophies. Excerpta Medica, Amsterdam-Oxford, 1977.

• 20) 里吉営二郎: 筋疾患の臨床. 日内会誌, 67: 1465-1481, 1978.

• 21) Sibley, J. A. and Lehninger, A. L.: Aldolase in the serum and tissues of tumor-bearing animals. J. Nat. Cancer Inst., 9: 303-309, 1949.
  pubmed

• 22) Sugita, H. and Tyler, F. H.: Pathogenesis of muscular dystrophy. Trans. Ass. Am. Phys., 26: 231-243, 1963.

• 23) Sugita, H, Ishiura S., Suzuki, K. and Imahori, K.: Ca++-activated neutral protease and its inhibitors. in vitro effect on intact myofibrils. Muscle Nerve, 3: 335-339, 1980.
  pubmed

• 24) 杉田秀夫: 進行性筋ジストロフィー症-成因に関する最近の進歩-. 日本医事新報 No.3061: 3-7, 1982.

• 25) 豊倉康夫, 古川哲雄: 進行性筋ジストロフィー症に関する古典から. 筋肉病学 (里吉営二郎, 豊倉康夫編), 南江堂, 東京, p. 363-386, 1973.

• 26) Walton, J. N. and Nattrass, F. J.: On the classification, natural history and treatment of the myopathies. Brain, 77: 169-231, 1954.
  pubmed

• 27) Walton, J. N. and Gardner-Medwin, D.: Progressive muscular dystrophy and the myotonic disorders. In``Disorders of voluntary muscle (ed. by Walton, J. N.), London, Churchill, P. 481-524, 1981.

• 28) Welander, L.: Myopathia distalis tarda hereditaria. 294 examined cases in 72 pedigrees. Acta Med. Scand., 141 (Suppl. 265): 1-124, 1951.

• 29) World Federation of Neurology, Research Group on Neuromuscular Diseases: Classification of the neuromuscular disorders: . J. Neurol. Sci., 6: 165, 1968.

• 30) 難病の発症機構に関する基礎的研究. 文部省特定研究「難病」班 昭和49, 50, 51, 52, 53, 54年度研究業績.

• 31) 特集: 筋ジストロフィー症研究の進歩. 最新医学, 35: 882-1007, 1980.

• 32) 特集: 筋ジストロフィー症. 神経進歩, 24: 693-837, 1980.

• 33) The muscular dystrophies. British Medical Bulletin, 36: 105-197, 1980.

• 34) 筋ジストロフィー症に関する研究. 厚生省「神経疾患研究委託費」研究班 (基礎班, 実験動物班, 成因・臨床班, 疫学・臨床班, 療護班) 昭和53, 54, 55, 56年度研究報告書.

P.171 掲載の参考文献

• 1) Fukuyama, Y. et al.: Apeculiar form of congenital progressive muscular dystrophy. Report of fifteen cases. Paediatria Universitatis Tokyo, 4: 5, 1960.

• 2) 福山幸夫: 小児科領域の筋疾患. 臨床神経学, 1: 409, 1961.

• 3) 大澤真木子, 他: 先天型進行性筋ジストロフィー症, 最新医学, 35: 988, 1980.
  Medical*Online

• 4) 大澤真木子, 他: 先天型進行性筋ジストロフィー症 (福山型) の遺伝・臨床・病理. 神経進歩, 24: 702, 1980.

• 5) 大澤真木子, 他: 先天型進行性筋ジストロフィー症. 小児内科, 12: 2567, 1980.

• 6) 印藤克彦, 他: 先天性筋ジストロフィーの1剖検例 (抄) . 日病誌, 59: 194, 1970.

• 7) 岩瀬勝彦, 他: 先天性進行性筋ジストロフィーの1例. 小児科, 12: 363, 1971.

• 8) 塚越広, 他: 福山型先天性筋ジストロフィー症の一剖検例. 冲中重雄 (編) 厚生省進行性筋ジストロフィー症研究班業績集 (II): 50, 1973.

• 9) 粕渕康郎, 他: 水頭症を伴った先天性筋ジストロフィー症の剖検例. 脳と発達, 6: 36, 1974.

• 10) Murakami, T. et al.: Congenital muscular dystrophy associated with micropolygyria, Report of two cases. Acta Pathol Jap. 25: 599, 1975.

• 11) 三宅捷太, 他: 水頭症と後頭部皮膚洞を伴った先天性筋ジストロフィー症の1例. 脳と発達, 9: 212, 1977.

• 12) 高田邦安, 他: 先天性筋ジストロフィーの1剖検例-脳奇形とその発生について-. 神経進歩, 22: 582, 1978.

• 13) Mukoyama, M. et al.: The brain pathology in Fukuyama type congenital muscular dystrophy. Jap. J. Med. 181: 218, 1979.

• 14) 篠田実, 他: 先天性筋ジストロフィー症の1剖検例. 祖父江逸郎 (班長): 厚生省神経疾患研究委託費筋ジストロフィー症の臨床病態および疫学的研究, 昭和53年度研究報告書, pp. 235, 1979年3月.

• 15) 飯田政雄, 他: 先天型筋ジストロフィー症の病理組織学的研究. 昭和53年度研究報告書, pp. 238. 1979年3月.

• 16) 藤井舜輔, 他: 先天性筋ジストロフィー症 (福山型) の一剖検例. 厚生省神経疾患研究委託費, 筋ジストロフィー症の臨床病態および疫学的研究班, 昭和54年度班会議 (班長 祖父江逸郎) 東京, 1979年, 12月.

• 17) Fowler, M. et al.: Congenital muscular dystrophy with malformation of central nervous system. Kakulas, B. A. (ed.) Clinical Studies in Myology. Proceedings of the 2nd International Congress of Muscle Diseases, Perth, 1971, Exerpta Medica, Amsterdam, P. 192, 1973.

• 18) Krijgsman, J. B., et al.: "Congenital muscular dystrophy and cerebral dysgenesis in a Dutch family. Neuropadiatrie 11: 108, 1980.

• 19) Peters, A. C. B.: Personal communication

• 20) 大澤真木子: 先天型進行性筋ジストロフィー症 (福山型) の遺伝学的ならびに疫学的研究. 東女医大誌, 48: 204, 1978.

• 21) Takeshita, K., et. al.: Survey of Duchenne type and congenital type of muscular dystrophy in Shimane, Japan. Jap. J. Human Genet. 22: 43, 1977.

• 22) Chou, S.: 福山型先天性筋ジストロフィー症の神経病理に関する再検討. 昭和51年度厚生省心身障害研究費補助金研究課題「進行性筋ジストロフィー症の成因と治療に関する研究」班会議. (東京), 1976, 12月,

• 23) Kamoshita, S., et al.: Congenital muscular dystrophy as a disease of the central nervous system. Arch. Neurol. 33: 513, 1976.
  pubmed

• 24) 鴨下重彦: 先天型筋ジストロフィー症 (福山型) の成因. 日本臨牀, 35: 3929, 1977.

• 25) Misugi, N.: Light and electron microscopic studies of congenital muscular dystrophy. Brain Dev. 2: 191, 1980.
  pubmed

• 26) 菊地延子: 先天性筋ジストロフィーの運動療法, 12: 383, 1978.

• 27) 瀬川昌也: 先天性筋ジストロフィー症 (知能障害, 顔面筋罹患を伴う関節拘縮型先天性筋ジストロフィー症) の臨床的研究. 脳と発達, 2: 439, 1970.

• 28) 飯沼一宇 他: 先天性筋ジストロフィー症における中枢神経系の障害について. 脳と発達, 6: 340, 1974.

• 29) 瀬川昌也: 先天性筋ジストロフィー症. 神経進歩. 20: 68, 1976.

• 30) 青山正征, 他: 先天性筋ジストロフィー症 (福山型) に合併した"点頭てんかん"の発作時脳波について. 東女医大誌, 47: 638, 1977.

• 31) 渋谷温, 他: 先天性筋ジストロフィー症に点頭てんかんを合併した1女児例, 小児科臨床, 30: 1701, 1977.

• 32) 桑島克子, 他: 水頭症を伴った重症心身障害児にみられた進行性筋ジストロ フィー症の1例. 脳と発達, 6: 29, 1974.

• 33) 三杉信子, 他: Tubular structureを認めた先天性筋ジストロフィー症の1例. 脳と発達, 10: 335, 1978.

• 34) 平山義人, 他: 進行性筋ジストロフィー症の脳波, 臨床脳波, 19: 714, 1977.

• 35) Segawa, M., et al.: Fukuyama type congenital muscular dystrophy as anatural model of childhood epilepsy. Brain and Development. 1: 113, 1979.

• 36) 福山幸夫, 他: 先天型進行性筋ジストロフィー症の中枢神経異常に関する神経放射線学的検討. 冲中重雄 (編) 筋ジストロフィー症の病因究明に関する研究. 昭和51年度研究報告書. p. 116, 1977年, 3月.

• 37) Osawa, M., et al.: Computerized tomography (CT) in patients with progressive muscular dystrophy (PMD) . Second International Child Neurology Congress Sydney, Australia, 1979.

• 38) 本田孔士, 他: 筋ジストロフィー症の眼所見について. 眼科臨床医報, 72: 1483, 1978.

• 39) Ando, T., et al.: Myoglobinemia in children with progressive muscular dystrophy. Clinica Chimica. Acta. 85: 17, 1978.

• 40) 福山幸夫, 他: 先天型筋ジストロフィー症 (福山型) における血清ウイルス抗体価. 祖父江逸郎 (班長): 厚生省神経疾患研究委託費, 筋ジストロフィー 症の臨床病態および疫学的研究. 昭和53年度研究報告書, pp. 225. 1979年3月.

• 41) 文田明仙, 他: 福山型Congenital muscular dystrophyにおけるCTと mycoplasma感染の可能性について. 神経内科, 9: 49, 1978.

• 42) Jervis, G. A.: Progressive muscular dystrophy with extensive demyelimation of the brain. J. Neuropath. Exp. Neurol., 14: 376, 1955.

• 43) 和田正士, 他: DMP剖検例の検討. (班長) 祖父江逸郎, 厚生省神経疾患研究委託費, 筋ジストロフィー症の臨床病態および疫学的研究班, 昭和54年度 研究報告書, pp317, 1980年, 3月.

• 44) 瀬川昌也: 先天性筋ジストロフィー症 (知能障害, 顔面筋疾患を伴う関節拘縮型先天性筋ジストロフィー症) の生検筋における組織学的, 組織化学的, および電子顕微鏡学的研究. 脳と発達, 3: 21, 1971.

• 45) 埜中征哉, 他: 先天性筋ジストロフィー (福山型) の臨床及び筋組織所見. 小児科診療, 35: 964, 1972.

• 46) 埜中征哉, 他: 先天性筋ジストロフィー症生検筋にみられるsatellite細胞の電子顕微鏡的研究. 脳と発達, 5: 520, 1973.

• 47) 上田敏, 他: 先天性筋ジストロフィー症 (福山型) のリハビリテーション50 例についての臨床分析. 総合リハビリテーション, 3: 51, 1975.

• 48) 菊地延子: いわゆる非定型タイプの先天性筋異栄養症児の歩行不能になるまでの過程-2例のケースの検討より. 理学療法と作業療法, 8: 749, 1974.

• 49) Donner, M. . et al.: Congenital muscular dyptrophy: aclinico-pathological and follow-up study of 15 patients. Neuropadiatrie. 6: 239, 1975.

• 50) Dubowitz, V.: Congenital muscular dystrophy. Dubowitz, V.: Muscle Disorders In Childhood. W. B. Saunders Co. Ltd. London, Philadelphia, Tronto, PP. 59-64. 1978.

• 51) Jones, R., et al: Congenital muscular dystrophy. J. Bone Joint Surgery. 61-B: 13, 1979.

• 52) Lazaro, R. et al.: Congenital muscular dystrophy: case reports and reappraisal. Muscle and Nerve. 2: 349, 1979.
  pubmed

• 53) Lenard, H-G., et al.: Congenital muscular dystrophies and unstructured congenital myopathies. Brain Dev. 2: 119, 1980.
  pubmed

• 54) 三嶋一弘, 他: Ullrich型先天性筋ジストロフィー症 (Die Kongenitale atonisch-sklerotishe Muskeldystrophie) の一剖検例について. 脳と発達, 5: 530, 1973.

• 55) 埜中征哉, 他: Ullrich型先天性筋ジストロフィー (kongenitale, atonisch-sklerotische Muskeldystrophie) 症の臨床的及び筋組織学的検討. 脳と発達, 6: 48, 1974.

• 56) Furukawa, T., et al.: Congenital hypotonic-sclerotic muscular dystrophy. JMed. Genet 14: 426, 1977.

• 57) Nihei, K., et al: Acase of Ullrich: s disease. Brain Dev. 1: 61, 1979.

P.180 掲載の参考文献

• 1) Caughey, J. E. & Myrianthopoulos, N. C.: Dystrophia myotonica and related disorders. Charles C. Thomas, Springfield, 1963.

• 2) Harper, P. S.: Myotonic dystrophy. Saunders, Philadelphia, 1979.

• 3) Roses, AD., Harper, P. S. & Bossen, EH.: Myotonic muscular dytro phv in Handbook of clinical neurology (ed. by Vinken, PJ. & Bruyn, G. W.) Vol. 40, North-Holland, Amsterdam, PP. 485-532, 1979.

• 4) Thomsen, J.: Tonische Krampfe in willkurlich beweglichen Muskeln in Folge von ererbter psychischer Disposition (Ataxia muscularis?) Arch. Psychiatr. Nervenkr. 6: 702-718, 1876.

• 5) Hoffmann, J.: Zur Lehre von der Thomsen: schen Krankheit mitbesonderer Beruksichtigung des dabei vorkommenden Muskelschwun. des. Dtsch. Z. Nervenheilkd. 18: 197-216, 1900.

• 6) Rossolimo, G.: De la myotonie atrophique. Nouv. Iconogr. Salpetriere 15: 63-77, 1902.

• 7) Steinert, H.: Myopathologische Beitrage. I Uber das klinische und anatomische Bild des Muskelschwunds der Myotoniker, mit einer Mitteilung zur Kenntnis des tabiformen Hinterstrangsdegenerationen. Dtsch. Z. Nervenheilkd. 37: 58-104, 1909.

• 8) Greenfield, J. G.: Notes on a family"myotonia atrophica"and early cataract, with a report on an additional case of myotonia atrophica, Rev. Neurol. Psychiatry (Edinburgh) 9: 169-181, 1911.

• 9) Caughey, J. E.: Relationship of dystrophia myotonica (myotonic dystrophy) and myotonia congenita (Thomsen's disease) . Neurology (Minneap.) 8: 469-476, 1958.

• 10) Church, S. C.: The heart in myotonia atrophica. Arch. Intern. Med. 119: 176-181, 1967.
  pubmed

• 11) Kuhn, E. & Ey, W.: Innenohrschwerhorigkeit bei Dystrophia myotonica und Dystrophia muscularis progressiva. Dtsch. Med. Wochenschr. 91: 947-951, 1966.
  pubmed

• 12) Brooke, M. H. & Engel, W. K.: The histographic analysis of human muscle biopsies with regard to fiber types. 3. Myotonias, myasthenia gravis, and hypokalemic periodic paralysis. Neurology (Minneap.) 19: 469-477, 1969.

• 13) Wochner, R. D., Drews, G., Strober, W. et al.: Accelerated breakdown of IgG in myotonic dystrophy. J. Clin. Invest. 45: 321-329, 1966.
  pubmed

• 14) Bundey, S. & Carter, W.: Genetic heterogeneity for dystrophia myotonica J. Med. Genet. 9: 311-315, 1972.

• 15) Vanier, T. M.: Dystrophia myotonica in childhood. Br. Med. J. 2: 1284-1288, 1960.
  pubmed

• 16) Harper, P. S. & Dyken, P. R.: Early onset dystrophia myotonica-evidence supporting a maternal environmental factor. Lancet 2: 53-55, 1972.
  pubmed

• 17) Dyken, P. R. & Harper, P. S.: Congenital dystrophia myotonica. Neurology (Minneap.) 23: 465-473, 1973.

• 18) Harper, P. S.: Congenital myotonic dystrophy in Britain. 2. Genetic basis. Arch. Dis. Child. 50: 514-521, 1975.

• 19) Karpati, G., Carpenter, S., Watters, G. V. et al.: Infantile myotonic dystrophy. Histochemical and electron microscopic features in skeletal muscle. Neurology (Minneap.) 23: 1066-1077, 1973.

• 20) Sarnat, H. B. & Silbert, S. W.: Maturational arrest of fetal muscle in neonatal myotonic dystrophy. Arch. Neurol. 33: 466-474, 1976.
  pubmed

• 21) Barbosa, J., Nuttall, F. Q., Kennedy, W. et al.: Plasma insulin in patients with myotonic dystrophy. Medicine (Baltimore) 53: 307-323, 1974.
  pubmed

• 22) Festoff, B. W. & Moore, W. V.: Evaluation of the insulin receptor in myotonic dystrophy. Ann. Neurol. 6: 60-65, 1979.
  pubmed

• 23) Roses, A. D. & Appel, S. H.: Muscle membrane protein kinase in myotonic muscular dystrophy. Nature 250: 245-247, 1974.
  pubmed

• 24) Roses, A. D. & Appel, S. H.: Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy. J. Membr. Biol. 20: 51-58, 1975.
  pubmed

• 25) Mishra, S. K., Hobson, M. & Desaiah, D.: Erythrocyte membrane abnormalities in human myotonic dystrophy. J. Neurol. Sci. 46: 333-340, 1980.
  pubmed

• 26) Becker, P.E.: Recessive generalized myotonia in Topics in human genetics. Vol. III (Myotonia congenita and syndromes associated with myotonia) . Georg Thieme, Stuttgart, pp. 61-109, 1977.

• 27) Eulenburg, A.: Uber eine familiare, durch 6 Generationen verfolgbare Form der congenitalen Paramyotonie. Zbl. Ges. Neurol. Psychiatr. 5: 265-272, 1886.

• 28) Schwartz, O. & Jampel, R. S.: Congenital blepharophimosis associated with a unique generalized myopathy. Arch. Ophthalmol. 68: 52-57, 1962.
  pubmed

• 29) Fariello, R., Meloff, K., Murphy, EG. et al.: Acase of Schwartz-Jampel syndrome with unusual muscle biopsy findings. Ann. Neurol. 3: 93-96, 1978.

P.197 掲載の参考文献

• 1) Walton, J. N. & Adams, R. D.: Polymyositis. P. I, Livingstone, Edinburgh & London. 1958.

• 2) Currie, S., Saunders, M., Knowles, M. & Brown, A. E.: Immunological aspects of polymyositis. Quart. J. Med., 40: 63, 1971.
  pubmed

• 3) Esiri, M. M., Maclennan, I. C. M. and Hazleman, B. L.: Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin. Exp. Immunol., 14: 25, 1973.

• 4) Dawkins, R.L. & Mastaglia, F. L.: Cell-mediated cytotoxicity to muscle in polymyositis. N. Engl. J. Med., 288: 434, 1973.
  pubmed

• 5) Mastaglia, F. L. & Currie, S.: Immunological and Ultrastructural observations on the role of lymphoid cells in the pathogenesis of polymyositis. Acta neuropath., 18: 1, 1971.
  pubmed

• 6) 高柳哲也, 小長谷正明, 三橋勝博, 祖父江逸郎: 多発性筋炎の末梢および筋内リンパ球の態度について. 厚生省特定疾患自己免疫疾患調査研究班昭和51年度研究業績, p.170, 1977.

• 7) 高柳哲也: 多発性筋炎の臨床と病態-抗原および免疫機構を中心に-. 第20 回日本医学会総会々誌, p.586, 1979.

• 8) Whitaker, J. N. & Engel, W. K.: Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N. Engl. J. Med., 286: 333, 1972.
  pubmed

• 9) Behan, W. M. H., Barkas, T. & Behan, P. O.: Detection of immune complexes in polymyositis. Acta. neurol. Scand., 65: 320, 1982.

• 10) 高柳哲也, 小寺良尚: 多発性筋炎における抗体依存性細胞破壊について. 厚生省特定疾患調査研究班昭和55年度研究業績, p. 334, 1981.

• 11) 高柳哲也, 本田仁, 榊原敏正, 小寺良尚: 多発性筋炎における抗体依存性細胞障害について, 同上昭和56年度研究業績, p. 442, 1982.

• 12) Fulthorpe, JJ. & Hudgson, P.: Immunocytochemical localization of immunoglobulins in the inflammatory lesions of polymyositis. J. Neuroimmunol., 2: 145, 1982.
  pubmed

• 13) Baumli, H. & Mumenthaler, M.: The perifascicular atrophy factor. An aid in the histological diagnosis of polymyositis. J. Neurol., 214: 129, 1977.
  pubmed

• 14) Walton, J. N. & Adams, R. D.: Polymyositis. P. 10, Livingstone, Edinburgh & London, 1958.

• 15) Cramer, S. F., Ruehl, A. & Mandel, M. A.: Fibrodysplasia ossificans progressiva. A distinctive bone-forming lesion of the soft tissue. Cancer, 48: 1016, 1981.
  pubmed

• 16) Connor, J. M. & Evans, D. A. P.: Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J. Bone& Joint Surgery, 64: 76, 1982.

• 17) 里吉営二郎: 多発性筋炎, 皮膚筋炎の診断基準・病型分類, 内科, 45: 1122, 1980.

• 18) 加茂久樹, 秋口一郎, 伊藤順子, 亀山正邦, 岡本英一: 悪性細網症を合併した多発性筋炎症候群の一剖検例. 臨床神経, 21: 767, 1981.

• 19) van Bogaert, L & Radermecker, M. A.: De quelques affections muscclaires primitives en dehors des myopathies. Edition des Acta Neurologica et Psychiatrica Belgica. I. 1954.

• 20) Pearson, C. M.: Polymyositis. Ann. Intern. Med., 59: 827, 1963.
  pubmed

• 21) Classification of the neuromuscular disorders. J. neurol Sci., 6: 165, 1968.
  pubmed

• 22) Bohan, A. & Peter, J. B.: Polymyositis and Dermatomyositis. N. Engl. J. Med., 292: 344, 1975.
  pubmed

• 23) 永田康夫, 加藤洋, 飯田光男, 祖父江逸郎: 名古屋市における Myopathy の疫学. 臨床神経, 4: 478, 1964.

• 24) Barwick, D. D. & Walton, J. N.: Polymyositis. Amer. J. Med., 35: 646, 1963.
  pubmed

• 25) Vignos, P.J., Bowling, G. F., & Watkins, M. P.: Polymyositis. Effect of cortrcosteroids on final result. Arch. Intern. Med., 114: 263, 1964.
  pubmed

• 26) Henriksson, K. G. & Sandsted, P.: Polymyositis-treatment and prognosis. A study of 107 patients. Acta neurol. Scand., 65: 280, 1982.

• 27) Rose, A. L. & Walton, J. N.: Rolymyositis: Asurvey of 89 cases with particular reference to treatment and prognosis. Brain, 89: 747, 1966.

• 28) 飯島進: 山崎啓二, 山辺靖夫, 北村四郎, 野内文雄, 末永守, 過足幸子: 皮膚筋炎の臨床と病理. 皮膚臨床, 3: 454, 1961.

• 29) 那須毅: 強皮症, 皮膚筋炎及び多発性筋炎の本邦剖検例における統計的観察 (第一報) . 厚生省特定疾患強皮症. 皮膚筋炎および多発性筋炎調査研究班昭和48年度研究業績, p.23, 1974.

• 30) Hollinrake, K.: Polymyositis presenting as distal muscle weakness. A case report. J. neurol. Sci., 8: 479, 1969.
  pubmed

• 31) Sundaram, M. B. & Ashenhurst, E. M.: Polymyositis presenting with distal and asymmetrical weakness. J. Canad. Sci. neurol, 8: 147, 1981.

• 32) 渡辺洋望. 皮膚筋炎・多発性筋炎. 臨床免疫, 14. 428, 1982.

• 33) Crowe, W. E., Bove, K. E., Levinson, J. E. & Hilton, P. K.: Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis, Arth. Rheum., 25: 126, 1982.

• 34) Isenberg, D. A. & Mckeran, R. O.: Astudy of vascular permeabilityin normal skeletal muscle and inflammatory myopathies using a fluorescein dye technique with percutaneous needle biopsy. J. neurol. Sci., 53: 423, 1982.

• 35) Messina, C., Bonanno, N., Baldari, S. & Vita, G.: Muscle uptake of 99m technetium pyrophosphate in patients with neuromuscular disorders J. neurol. Sci., 53: 1, 1982.
  pubmed

• 36) Salama, J., Tome, F. M. S., Lebon, P., Marie, L, Delaporte, P. & Fardeau, M.: Myosite a inclusions. Etude clinique, morphologique et virologique concernant une nouvelle observation associee a une sclerodermie generalisee et a un syndrome de Klinefelter. Rev. Neurol., 136: 863, 1980.

• 37) Chad, D., Good, P., Adelman, L., Bradley, W. G. & Mills, J.: Inclusionbody myositis associated with Sjogren: s syndrome. Arch. Neurol., 39 186: 1982.

• 38) Henriksson, K. G. & Stalberg, E.: The terminal innervation pattern in polymyositis: Ahistochemical and SFEMG study. Muscle&Nerve, 1: 3, 1978.
  pubmed

• 39) Sandstedt, E. R., Henriksson, K G. & Larsson, L.E.: Quantitative electromyography in polymyositis&dermatomyositis. A long-term study. Acta neurol. Scand. 65: 110, 1982.

• 40) Goto, I.: Creatine phosphokinase isozymes in neuromascular disorders. Arch. Neurol., 31: 116, 1974.

• 41) Arnett, F. C., Hirsch, TJ., Bias, W. B., Nishikai, M. & Reichlin, M.: The Jo-1 antibody system in myositis: Relationship to clinical features and HLA. J. Rheumatol., 8: 6, 1981.
  pubmed

• 42) Behan, W. M. H. & Behan, P. O.: Complement abnormalities in polymyositis. J. neurol. Sci., 34: 241, 1977.

P.213 掲載の参考文献

• 1) 宇尾野公義: 重症筋無力症, 金原出版, 東京, 1976.

• 2) Simpson, J. A.: Myasthenia gravis: anew hypothesis, Scot. Med. J. 5: 419-436, 1960.

• 3) Patrick, J. & Lindstrom, J.: Autoimmune response to acetylcholine receptor, Science, 180: 871-872, 1973.
  pubmed

• 4) Almon, R. R., Andrew, C. G. & Appel, S. H.: Serum globulin in myasthenia gravis: inhibition of α-bungarotoxin binding to acetylcholine receptor, Science, 186: 55-57, 1974.

• 5) Appel, S. H., Almon, R. R. & Levy, N: Acetylcholine receptor antibo. dies in myasthenia gravis, New Engl J. Med. 293: 760-761, 1975.

• 6) Elmqvist, D., Hofmann, W. W., Kugelberg, J. & Quastel, D. MJ.: An electrophysiological investigation of neuromuscular transmission in myasthenia gravis, J. Physiol., 174: 417-434, 1964.

• 7) Engel, A. G. & Santa, T.: Histometric analysis of the tlltrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome, Ann N. Y. Acad Sci, 183: 46-63, 1971.
  pubmed

• 8) Fambrough, D. M., Drachman, D. B. & Satyamurti, S.: Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors, Science, 182: 293-295, 1973.
  pubmed

• 9) Lindstrom, J. M., Seybold, M. E., Lennon, V. A., Whittingham, S. & Duane, DD.: Antibody to acetylcholine receptor in myasthenia gravis, Neurology, 26: 1054-1059, 1976.
  pubmed

• 10) Bradley, RJ., Dwyer, D., Morley, BJ., Robinson, G. Kemp, GE. & OH, S. J.: Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment, Prog. Brain. Res., 49: 441-448, 1979.
  pubmed

• 11) Tindall, R. S. A.: Humoral immunity in myasthenia gravis: effect of steroids and thymectomy, Neurology, 30: 554-557, 1980.
  pubmed

• 12) Pinching, AJ., Peters, D. K. & Davis J. N.: Remission of myasthenia gravis following plasma-exchange, Lancet. 2: 1373-1376, 1976.

• 13) Dau, P. C., Lindstrom, J. M., Cassel, CK., Denys, E. H., Shev, E. E., & Spitler, L.E.: Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis, New Engl. J. Med. 297: 1134-1140, 1977.
  pubmed

• 14) Drachman, D. B.: Acetylcholine receptors and myasthenia gravis, Proc. Soc. Exp. Biol. Med. 162: 26-30, 1979.
  pubmed

• 15) 渡辺裕: 胸腺腫の病理, 厚生省特定疾患重症筋無力症調査研究班. 昭和48年度研究報告書, 23-25頁, 昭和49年.

• 16) 玉置憲一: 胸腺.胸腺腫調査集計結果について, 厚生省特定疾患重症筋無力 症調査研究班. 昭和50年度研究報告書, 12-17頁, 昭和51年.

• 17) Osserman, KE. & Genkins, G.: Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients, Mt. Sinai. J. Med. 38: 497-537, 1971.
  pubmed

• 18) Goldman, AJ., Herrmann, C, Keesey, J., Mulder, D. G. & Brown, W. J.: Invasive thymoma and myasthenia gravis: atwenty-year experience, Trans Amer Neurol Assoc, 100: 192-194, 1975.

• 19) 平山宗宏, 杉下知子: 重症筋無力症の疫学的研究, 厚生省特定疾患重症筋無力症調査研究班, 昭和48年度研究報告書, 50-66頁, 昭和49年.

• 20) Desmedt, J. E.: The neuromusclar disorder in myasthenia gravis, 1. electrical and mechanical response to nerve stimulation in hand muscles, in New Development in Electromyography and Clinical Neurophysiology, ed. by Desmedt, J. E., vol 1, Karger, Basel, 241-304, 1973.

• 21) Stalberg, E.: Single fiber: electromyography, DISA information department, Copenhagen, 1974.

• 22) 土屋雅春: Pneumomediastinography, 最新医学, 28: 1355-1361, 1973.

• 23) Keesey, J., Bein, M., Mink, J., Sample, F., Sarti, D., Mulder, D., Herrmann, C. & Peter, J. B.: Detection of thymoma in myasthenia gravis, Neurology, 30: 233-239, 1980.
  pubmed

• 24) 広瀬和彦: 重症筋無力症・筋無力症症候群, in 神経難病 (宇尾野公義編) 金原出版, 東京, 305-327, 1979.

• 25) Drachman, D. B.: Myasthenia gravis (second of two parts), New Engl. J. Med. 298: 186-193, 1978.
  pubmed

• 26) Matel, G., Bergstrom, K., Franksson, C., Hammarstrom, L., Lefvert, A. K., Moller, E, Von Reis, G. & Smith, E.: Effects of some immuno-suppressive procedures on myasthenia gravis, Ann. N. Y. Acad. Sci. 274: 659-676, 1976.

• 27) Papatestas, A. E., Alpert, L. I., Osserman, K. E., Osserman, R. S. & Kurk, A. E.: Studies in myasthenic gravis: effects of thymectomy, results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969, Amer. J. Med., 50: 465-474, 1971.

• 28) Emeryk, B. & Strugalska, M. H.: Evaluation of results of thymectomy in myasthenia gravis, J. Neurol., 211: 155-168, 1976.
  pubmed

• 29) Mertens, H. G. & Hertel, G.: Immunodepressive Behandlung der Myasthenien, Med. Welt., 24: 955-963, 1973.

• 30) Henson, R. A.: Neuromuscular disorders associated with malignant disease, ed. by J. N. Walton, 3rd Ed. Churchill&Livingstone, Edinburgh, 760-774, 1974.

P.221 掲載の参考文献

• 1) Westphal, C.: Ueber einen merkwurdigen Fall von periodischer Lahmung aller vier Exremitaten mit gleichzeitigem Erloschen der electrischen Erregbarkeit wahrend der Lahmung. Berl. Klin. Wochenschr., 22: 489, 1885.

• 2) Biemond, A. & Daniels, A. P.: Familial periodic paralysis and its transition into spinal muscle atrophy. Brain, 57: 91, 1934.

• 3) Gamstorp, I.: Adynamia episodica hereditaria. Acta Paediatr. 45 (Suppl. 108): 1, 1956.

• 4) Poskanzer, D. C., Kerr, D. NS.: A third type of periodic paralysis with normokalemia and favorable response to sodium chloride. Am. J. Med. 31: 328, 1961.

• 5) Okinaka, S., Shizume, K., Iino, S., Watanabe, A., Noguchi, A., Kuma S., Kuma, K., Ito, T.: The association of periodic paralysis and hyperthyroidism in Japan. J. Clin. Endocr, 17: 1454, 1957.
  pubmed

• 6) Engel, A. G.: Thyroid function and periodic paralysis. Amer. J. Med., 30: 327, 1961.
  pubmed

• 7) 里吉営二郎, 村上慶郎, 岡崎隆: Endocrine myopathy. 最新医学, 20: 1622, 1965.

• 8) Satoyoshi, E, Murakami K., Kowa H., Kinoshita M., Nishiyama Y.: Periodic paralysis in hyperthyroidism, Neurology, 13: 746, 1963.
  pubmed

• 9) Engel, A. G.: Hypokalemic and hyperkalemic periodic paralysis, In. Scientific Approaches to Clinical Neurology. ed. by Goldensohn E. S. & Appcl S. H., Lea&Febiger, Philadelphia, 1977.

• 10) Goldflam, S.: Weitere Mitteilung Uber die paroximale familiare Lahmung. Dentsch Z. Nervenheilk. 7: 1, 1895.

• 11) Streeton, D. HP.: Periodic paralysis. The Metabolic Basis of Inherited Disease (Stanbury, J. B. et al. ed.) 1966.

• 12) Shy, GM., Wanko, T., Rowley, P. T., Engel, AG,: Studies in familial periodic paralysis. Exp. Neurol., 3: 53, 1961.

• 13) Dyken, M. L, Zeman, W., Rusche, T.: Hypokalemic periodic paralysis: Children with permanent myopathic weakness. Neurology, 19: 691, 1969.

• 14) Pearson, C. M.: The periodic paralysis: Differential features and pathological observations in permanent myopathic weakness. Brain. 87: 341, 1964.
  pubmed

• 15) Grob, D., John, R. J., Liljestrand, A.: Potassium movements in patients with hypokalemic periodic paralysis. Am. J. Med. 23: 356, 1957.

• 16) 大塚, 真崎, 大槻: インスリンによる筋麻痺の機構, 特に周期性四肢麻痺との関連, 日薬理誌, 60: 50, 1964.

• 17) Creutzfeldt, O. D., Abbott, B. C., Fowler, W. M., Pearson, C. M.: Muscle membrane potentials in episodic adynamia. Electroenceph. Clin. Neurophysiol. 15: 508, 1963. 18) Goldman, DE.: Potential impedance and rectification in membranes. J. Gen. Physiol. 27: 37, 1943-1944.

• 19) Kao, I., Gordon, A. M.: Mechanism of insulin induced paralysis of muscle from potassiumdepleted rats. Science. 188: 740, 1975.
  pubmed

• 20) Hofmann, W. W., Smith, RA.: Hypokalemic periodic paralysis studied in vitro. Brain, 93: 445, 1970.

• 21) Viskoper, RJ., Licht, A., Fidel, J., Chaco, J.: Acetazolamide treatment in hypokalemic periodic paralysis: A metabolic and electromyographic Study. Am. J. Med. Sci. 266: 119, 1973.

• 22) Johnson, T.: Trial of the prophylactic effect of diazoxide in the treatment of familial periodic hypokalemia. Acta. Neurol. Scand. 56: 525, 1977.

P.237 掲載の参考文献

• 1) Brain, R. & Henson, R. A.: Neurological syndromes associated with carcinoma. The carcinomatous neuromyopathies. Lancet, 2: 971, 1958.
  pubmed

• 2) Brain, Lord&Adams, R.D.: Aguide to the classification and investigation of neurological disorders associated with neoplasms. In"The remote effects of cancer on the nervous system, "ed. by Brain, Lord Norris, F. H., Jr., Contemp. Neurol. Symp. Vol. 1, p. 216, 1965.

• 3) 高橋昭: その他の疾患に伴う神経症状, 悪性腫瘍. 新内科学大系, Vol.13, 神経疾患VI, 中山書店, 東京, p.341, 1975.

• 4) Croft, P. B. & Wilkinson, M.: The inddence of carcinomatous neuromyopathy wiih special references to carcinoma of the lung and the breast. In"The remote effects of cancer on the nervous system. "ed. by Brain, Lord&Norris, F. H., Jr., Comtemp. Neurol. Symp., Vol. 1, p. 44, 1965.

• 5) Croft, P. B. & Wilkinson, M.: The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain, 88: 427, 1965.
  pubmed

• 6) Wyburn-Mason, R.: Bronchial carcinoma presenting as polyneuritis. Lancet, 1: 203, 1948.
  pubmed

• 7) Denny-Brown, D.: Primary sensory neuropathy with muscular changes associated with carcinoma. J. Neurol. Neurosurg. Psychiatry, 11: 73, 1948.
  pubmed

• 8) Henson, R. A. & Urich, H.: Peripheral neuropathy associated with malignant disease. In "Handbook of clinical neurology", ed. by Vinken, P. J. & Bruyn, G. W., North-Holland Publ. Co., Amsterdam, Vol. 8, Pt. 2, p. 131, 1970.

• 9) McLeod, J. G.: Carcinomatous neuropathy. In"Peripheral neuropathy", ed. by Dyck, P. J., Thomas, P. K. & Lambert, E. H., Saunders, Philadelphia, P. 1301, 1975.

• 10) Horwich, M. D., Chol, L, Porro, R. S. & Posner, J. B.: Subacute sensory neuropathy. A remote effect of carcinoma. Ann. Neurol., 2: 7, 1977.

• 11) 冲中重雄, 豊倉康夫: 癌患者に伴う特異な神経症状 (carcinomatous neuropathy) . 最新医学, 10: 2297, 1955.

• 12) 渡辺到, 松山春郎, 石川七郎, 中川自夫, 三浦岱栄, 富永淳, 松本孝子: Carcinomatous neuropathyの1剖検例. 神経進歩, 8: 72, 1964.

• 13) 田村静夫. 癌性神経症を伴った肺癌の二剖検例. 癌の臨床, 15. 176, 1969.

• 14) 高津成美, 栗崎博司, 水沢英洋, 清水輝夫, 豊倉康夫: 食道扁平上皮癌に伴ったsensory neuropathy. 神経内科, 9: 464, 1978.

• 15) 並河正, 田平武, 大西晃生, 黒岩義五郎: 肺癌に伴う subacute sensoryneuropathy. 臨床神経, 20: 286, 1980.

• 16) Croft, P. B. & Wilkonson, M.: The course and prognosis in some types of carcinomatous neuromyopathy. Brain, 92: 1, 1969.

• 17) Croft, P. B., Urich, H. & Wilkinson, M.: Peripheral neuropathy ofsensorimotor type associated with malignant disease. Brain. 90: 31, 1967.

• 18) Norris, FH., Jr., McMenemey, W. H. & Barnard, R. O.: Anterior hornpathology in carcinomatous neuromyopathy compared with otherforms of motor neuron disease. In"Motor neuron diseases, Researchon amyotrophic lateral sclerosis and related disorders, "ed. by Norris, F. H., Jr. & Kurland, L. T., Grune&Stratton, New York&London, p. 100, 1968.

• 19) Schold, S. C., Cho, E. .S., Somasundaram, M. & Posner, JB.: Subacutemotor neuropathy. A remote effect of lymphoma. Ann. Neurol, 5: 271, 1978.

• 20) Walton, J. N. & Adams, R. D.: "Polymyositis", E&S Livingstone, Edinburgh&London, 1958.

• 21) Pearson, C. M.: Patterns of polymyositis and their responses to treatment. Ann. Intern. Med., 59: 827, 1963.
  pubmed

• 22) 那須毅, 発地雅夫, 酒井康弘, 菅沼龍夫: 強皮症・皮膚筋炎及び多発性筋炎の本邦剖検例における統計的観察 (第3報) . 昭和50年度厚生省特定疾患, 「強皮症・皮膚筋炎・多発性筋炎」研究業績, p. 46, 1976.

• 23) Anderson, HJ., Churchill-Davidson, H. C. & Richardson, A. T.: . Bronchial neoplasm with myasthenia. Lancet, 2: 1291, 1953.

• 24) Lambert, E. H., Eaton, L.M. & Rooke, ED.: Defect of neuromus cularconduction associated with malignant neoplasms. Am. J. Physiol., 187,: 612, 1956.

• 25) Eaton, L. M. & Lambert, EH.: Electromyography and electric stimulation of nerves in diseases of motor units: Observations on myasthenic syndrome associated with malignant tumors. J. A. M. A., 163: 1117, 1957.

• 26) Lambert, E. H. & Rooke, E. D.: Myasthenic state and Iung cancer. In"The remote effects of cancer on the nervous system, "ed. by Brain, Lord&Norris, F. H., Jr., Contemp. Neurol. Symp. 1, Grune&Stratton, New York&London, P. 67, 1965.

P.250 掲載の参考文献

• 1) Walton, J. N.: Amyotonia congenita. A follow-up study. Lancet, 1: 1023, 1956.

• 2) Shy, GM. & Magee, K. R.: Anew congenital non-progressive myopat. hy. Brain, 79: 610, 1956.

• 3) 田辺等, ほか: Central core disease: 脊椎側弩を伴った2例における臨床的, 組織化学的, 電顕的検討. 神経進歩, 20: 458, 1976.

• 4) Schotland, D. L.: An electron microscopic study of target fibers, target-like fibers and related abnormalities in human musple. J. Neuropathol. Exp. Neurol., 28: 214, 1969.
  pubmed

• 5) Schmitt, H. P. & Volk, B.: The relationship between target, targetoid, and targetoid/core fibers in severe neurogenic muscular atrophy. J. Neurol, 210: 167, 1975.
  pubmed

• 6) Engel, W. K., et al.: Histochemical studies of denervated or tenotomized cat muscle, Ann. N. Y. Acad. Sci., 138: 160, 1966.

• 7) Shy, G. M., et al.: Nemaline myopathy. A new congenital myopathy. Brain, 86: 793, 1963.
  pubmed

• 8) 向山昌邦, ほか: 筋線維内に多様なcoreを合併したnemaline myopathyの1例. 臨床神経, 17: 541, 1977.

• 9) Cape, C. A., et al: Nemaline structures in polymyositis. Neurology, 20: 494, 1970.
  pubmed

• 10) Rewcastle, N. B. & Humphrey, J. G.: Vacuolar myopathy. Arch.Neurol., 12: 570, 1969.

• 11) Engel, A. G.: Late-onset rod myopathy (a new syndrome?) . Mayo Clin. Proc., 41: 713, 1966.
  pubmed

• 12) Resnick, J. S., et al.: Changes in the Z disk of skeletal muscle induced by tenotomy. Neurology, 18: 737, 1968.
  pubmed

• 13) Shafiq, S. A., et al.: Tenotomy. Effect on the fine structure of the soleus of the rat. Arch. Neurol., 20: 625, 1969.
  pubmed

• 14) Osame, M., et al.: Experimental nemaline rods induced by anticholine sterase drug (neostigmine methylsulfate) . Proc. Japan Acad., 51: 598, 1975.

• 15) Sugita, H., et al.: Protein composition of rods in nemaline myopathy. In Basic Research in Myology (ed. by Kakulas, B. A.), American Elsevier Company, New York, 1973, P. 298.

• 16) Spiro, AJ., et al.: Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch. Neurol., 14: 1, 1966.

• 17) Sher, J. H., et al: Familial centronuclear myopathy. A clinical and pathological study. Neurology, 17: 727, 1967.
  pubmed

• 18) Campbell, M. J., et al.: Myotubular, centronuclear or peri-centronuclear myopathy?J. Neurol. Sci., 8: 425, 1969.
  pubmed

• 19) 祖父江逸郎, 向山昌邦: Myotubular myopathy. 脳と発達, 5: 507, 1973.

• 20) Engel, A. G., et al.: Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo clin .Proc,.46: 666, 1971.
  pubmed

• 21) 向山昌邦, ほか. Multicore disease. 臨床神経, 13. 221, 1973.

• 22) Brooke, M. H. & Engel, W. K.: The histographic analysis of human muscle biopsies with regard to fiber types. IV. Children: s biopsies. Neurology, 19: 591, 1969.

• 23) Brooke, M. H.: Congenital fiber-type disproportion. In Clinical Studies in Myology (ed. by Kakulas, B. A.), American Elsevier Company, New York, P. 147. 1973.

• 24) Engel, A. G., et al: Fingerprint body myopathy. A newly recogniz. ed congenital muscle disease. Mayo Clin. Proc., 47: 377, 1972.

• 25) Brooke, M. H. & Neville, H. F.: Reducing body myopathy. Neurology, 22: 829, 1972.

• 26) Dubowitz, V. & Brooke. M. H.: Miscellaneous. In Muscle Biopsy: A Modern Approach, W. B. Saunders, London, P. 347, 1973.

• 27) Tome, F. M. S. & Fardeau, M.: Congenital myopathy with"reducing bodies"in muscle fibers. Acta Neuropathol., 31: 207, 1975.

• 28) Cancilla, P. A., et al.: Familial myopathy with probable lysis of myofibrils in type I fibers. Neurology, 21: 579, 1971.
  pubmed

• 29) Jerusalem, F., et al: Sarcotubular myopathy. A newly recognized, benign, congenital, familial muscle disease. Neurology, 23: 897, 1973.
  pubmed

• 30) Lake, B. D. & Wilson, J.: Zebra body myopathy. J. Neurol. Sci., 24: 437, 1975.
  pubmed

• 31) Ringel, S. P., et al.: Anew congenltal neuromuscular disease with trilaminar fibers. (Abstr.) . Neurology, 27: 347, 1977.

P.259 掲載の参考文献

• 1) Dyck, P.J., Definition and Basis of Classification of Hereditary Neuro pathy with Neuronal Atrophy and Degeneration;Peripheral Neuro-pathy, Dyck, PJ., Thomas, PK. and Lambert, EH. ed., Vol. ll, P.791-824, W. B, Saunders Co. Philadelphia, London, Toronto, 1975.

• 2) Classification of the Neuromuscular Disorders, Minutes of the Meeting of the Research Group on Neuromuscular Disease. J. Neurol. Sci, 6: 165, 1968.

• 3) Dyck, P.J., Lambert, H. E.: Lower motor and primary sensory neurondiseases with peroneal muscular atrophy I. Neurologic, Genetic and Electrophysiologic Findings in Hereditary polyneuropathies. Arch. Neuro. 18: 603, 1968.

• 4) Dyck, P.J., Lambert, HE.: Lower motor and primary sensory neuron disease with peroneal muscular atrophy II. Neurologic, Genetic and Electrophysiologic Findings in Hereditary Polyneuropathies. Arch. Neuro. 18: 619, 1968.

• 5) Dejerine, J., Sottas, J.: Sur la nevrite interstitielle, hypertrophique etprogressive de I: enfance;affection souvent familiale et, a debut infantile caracterisee par une atrophie musculaire des extremities, avec troubles marques de la sensibilite et ataxie des mouvements et relevant d'une nevrite interstitielle hypertrophique a marche as cendante, avec lesions modullaires consecutives. Compt. rend. Soc. de biol. 5: 63, 1893.

• 6) 古川哲雄, 塚越広, 椿忠雄: 経過中寛解を示したDejerine-Sottas病の1例. 臨床神経学, 4: 590, 1964.

• 7) Refsum, S.: Heredopathia atactica polyneuritiformis: Familial syndromenot hitherto discribed: Contribution to Clinical study of hereditarydisease of nervous system. Acta Psychiat. Neurol. Suppl. 38: 303, 1946.

• 8) Refsum, S.: Heredopathia atactica polyneuriformis (Refsum: s disease) Peripheral Neuropathy, Dyck, PJ., Thomas, P. K., and Lambert, E. H., ed., Vol. ll, P. 868-890, W. B. Saunders Co. Philadelphia, London, Toronto, 1975.

• 9) Steinberg, D.: Phytanic acid storage disease: Refsum: s syndrome. The metabolic basis of inherited disease, Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S. ed., McGraw-Hill, New York, 3rd ed., P. 833-853, 1972.

• 10) Steinberg, D. et al.: Phytanic acid in patients with Refsum: s syndromeand response to dietary treatment. Arch. Inter. Med., 125: 75, 1970.

• 11) Andrade, C.: Apeculiar form of peripheral neuropathy: Familialatypical: generalized amyloidosis with special involvement of peripheral nerve. Brain, 75: 408, 1952.

• 12) Rukavina, J. et al.: Primary Systemic Amyloidosis: A review andan experimental genetic and clinical study of 29 cases with particular emphasis on familial form, Medicine. 35: 239, 1956.

• 13) 荒木淑郎, 他: アミロイドニューロパチーの臨床, 日本臨牀, 25: 1570, 1967.

• 14) 鬼頭昭三, 他: 家族性amyloidpolyneuropathyのfocus, 日本臨牀, 31: 2326, 1973.

• 15) Glenner, G. G., Ignaczak, T. F. and Page, D. L.: The inherited systemic amyloidosis and localized amyloid deposits;The metabolic basis of inherited disease, Stansbury, J. B., Wyngaarden, J. B., Fredrickson, D. S. ed. P. 1308-1339, McGraw-Hill, New York, 1978.

• 16) Denny-Brown, D.: Hereditary sensory radicular neurophathy: J. Neurol. Neurosurg. Psy. 14: 237, 1951.

• 17) Kuroiwa, Y., Murai, Y.: Hereditary sensory radicular neuropathy with special reference to conduction velocity study. Neurology. 14: 574, 1964.
  pubmed

• 18) Dyck, PJ. and Ohta, M.: Neuronal atrophy and degeneration predominantly affecting peripheral sensory neurons: Peripheral Neuropathy., Vol. II, P. 791-824, W. B, Saunders Co. Philadelphia, London, Toronto, 1975.

5. 糖原病の分類・鑑別診断

P.275 掲載の参考文献

• 1) Ockerman, P. A.: Glycogen storage disease in Sweden. Acta. Paediat. Scand., 160: 5, 1965.

• 2) Snapper, I. and Van Creveld, S.: Un cas d'hypolycemie avec acetonemie chez un enfant. Bull. Soc. Med. Hop. Paris, 52: 1315, 1928.

• 3) Von Gierke, E.: Hepato-nephro-megalia glykogenica (Glykogen-speicherkrankheit der Leber und Nieren) . Beitr. Path. Anat., 82: 497, 1929.

• 4) Schonheimer, R.: Uber eine eigen artige Storung des kohlenhydratstoffwechsels. Z. Physiol. Chem., 182: 148, 1929.

• 5) Pompe, J. C.: Over idiopathische hypertrophie van het hart. Ned. T. Geneesk, 76: 304, 1932.

• 6) Cori, G. T.: Glycogen structure and enzyme deficiencies in glycogen storage disease. Harvey Lect., 48: 145, 1952-53.
  pubmed

• 7) Cori, G. T.: Biochemical aspects of glycogen deposition diseases. Mod. Prob. Paediat., 3: 344, 1957.

• 8) McArdle, B.: Myopathy due to a defect in muscle glycogen breakdown. Clin. Sci., 10: 13, 1951.
  pubmed

• 9) Tarui, S. et al.: Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenesis. Biochem. Biophys. Res. Commun., 19: 517, 1965.

• 10) Lewis, P. Rowland: Glycogen-storage disease of muscle. In Scientific Approaches to Clinical Neurology. edited by Goldensohn, E. S. and Appel, S. H., 1977. pp. 1692-1714.

• 11) Rosenstein, BJ.: Glycogen storage disease of the heart in a new born infant. J. Paediat., 65: 126, 1964.

• 12) Clement, D. H. and Godman, G. C.: Glycogen disease resembling mongolism, cretinism, and amyotonia congenita. Case report and review of literature. J. Pediat. 36: 11, 1950.

• 13) Hogan, G. R. et al.: Pompe's disease. Neurology, 19: 894, 1969.

• 14) Huijing, F. et al.: Diagnosis of generalized glycogen storage disease (Pompe's disease) . J. Paediat., 63: 984, 1963.

• 15) Salafsky, L.S. and Nadler, H. L.: Deficiency of acid α-glucosidase in urine of patients with Pompe's disease. J. Paediat. 82: 294, 1973.

• 16) Dancis, J. .et al.: Absence of acid maltase in glycogenosis type 2 (Pompe's disease) in tissue culture. Amer. J. Dis. Child., 117: 108, 1969.
  pubmed

• 17) Salafsky, I.S. and Nadler, H. L.: α-1, 4-glucosidase activity in Pompe's disease. J. Paediat., 79: 794, 1971.

• 18) Engel, A. G. et al.: The spectrum and diagnosis of acid maltase deficiency. Neurology, 23: 96, 1973.

• 19) Dincsoy, M. Y. et al.: Generalized glycogenosis and associated endo cardial fibroelastosis. J. Paediat., 67: 728, 1965.

• 20) Bernheim, M. et al.: Glycogenose cardiomusculaire chez un nourrison, etude anatomoclinique biologique, Pediatrie, 16: 267, 1961.

• 21) Lauer, R. M. et al.: Administration of a mixture of fungal glucosid ases to a patient with type II. glycogenosis (Pompe's disease) . Paediatrics, 42: 672, 1968.

• 22) Nadler, H. L. and Messina, A. M.: In utero detection of type II glyco genosis (Pompe's disease) . Lancet, 2: 1277, 1969.

• 23) Neustein, H. B.: Fine structure of skeletal muscle in type III glycogenosis. Arch. Path., 88: 130, 1969.

• 24) Hug, G.: Glucagon tolerance test in glycogen storage disease. J. Pediat., 60: 545, 1962.
  pubmed

• 25) Hers, H. G. et al.: The determination of amylo-1, 6-glucosidase. Europ. J. Biochem., 2: 257, 1967.
  pubmed

• 26) Williams, H. E.: Alpha-glucosidase activity in human leucocytes. Biochim. Biophys. Acta. 124: 34, 1966.
  pubmed

• 27) 垂井清一郎: 糖原病, 診断と治療 68: 1789, 1980.

• 28) Rowland, L.P. et al.: McArdle: s disease. Hereditary myopathy due to absence of muscle phosphorylase. Arch. Neurol, 9: 325, 1963.
  pubmed

• 29) Rowland, L. P. et al.: The clinical diagnoses of Mcardle: s disease. Identification of another family with deficiency of muscle phosphorylase. 16: 93, 1966.
  pubmed

• 30) Schotland D. L. et al.: Ultrastructural studies of muscle in Mcardle: s disease. J. Neurolpath. Exp. Neurol. 24: 629, 1965.
  pubmed

• 31) Wolf, H. P.: Fructose in McArdle: s syndrome. Lancet, 2: 937, 1962.

• 32) Layzer, R. B., Rowland, L. P. and Ranney, H. M.: Muscle phosphofructokinase deficiency, Arch. Neurol., 17: 512, 1967.
  pubmed

• 33) Tobin, W. E. et al.: Muscle phosphofructokinase deficiency. Arch. Neurol., 28: 128, 1973.
  pubmed

• 34) DiMauro, S., Rowland, L. P. and DiMauro, P.: Control of glycogen metabolism in human muscle. Evidence from glycogen storage diseases. Arch. Neurol., 23: 534, 1970.
  pubmed

• 35) Engel, W. K, Eyerman, E. L. and Williams, H. E.: Late-onset type of skeletal muscle phosphorylase deficiency. A new familial variety with completely and partially affected subjects. New Eng. J. Med., 268: 135, 1963.

• 36) Sluga, E., Seitelberger, F. and Moser, K.: Uber eine progressive Myopathie mit Muskelphosphorylasemangel und Riesenmitochondrian. Wien, Klin. Wshr., 49: 917, 1967.

• 37) Hudgson, P. et al.: Adult myopathy from glycogen storage disease due to acid maltase deficiency, Brain. 91: 435, 1968.
  pubmed

• 38) Holmes, J. M., Huughton, C. R. and Woolf, A. L.: Amyopathy present ing in adult life with features suggestive of glycogen storage disease, J. Neurol Neurosurg. Psychiat., 23: 302, 1960.

• 39) Engel, A. G, et al.: The spectrum and diagnosis of acid maltase deficiency. Neurolgy. 23: 95, 1973.

• 40) Chui, L.A. & Munsat, T. L.: Dominant inheritance of McArdle syndrome, Arch. Neurol. 33: 636, 1967.